
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says. Eight patients have not had their pancreatic cancer recur for three years after their immune systems responded to the vaccine, which is called autogene cevumeran, researchers reported… read on > read on >